![]() Paratek Pharmaceuticals Paratek Pharmaceuticals is focused on the discovery, development, and commercialization of medicines designed to save lives and alleviate suffering. | ![]() QGel QGel synthetic extracellular matrices mimic the complex physiology of the human body to bring predictability & efficiency to drug discovery & diagnostics. | ![]() Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | |
Founding Date | Founding Date 1996 | Founding Date 2009 | Founding Date 1935 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Boston, US HQ King Of Prussia, US | Locations Lausanne, CH HQ | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more |
Employees | Employees 10123% increase | Employees 147% decrease | Employees 27,764 |
Financial | |||
Revenue (est.) | Revenue (est.) $160.3m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) ₹277.1b (FY, 2026) |
Cost of goods | Cost of goods $23.1m (FY, 2022) | Cost of goods N/A | Cost of goods ₹95.5b (FY, 2026) |
Gross profit | Gross profit $137.2m (FY, 2022) | Gross profit N/A | Gross profit ₹195b (FY, 2026) |
Net income | Net income ($63.6m) (FY, 2022) | Net income N/A | Net income ₹38.7b (FY, 2026) |
Funding | |||
Total funding raised | Total funding raised $ 93m | Total funding raised $ 12m | Total funding raised N/A |

QGel synthetic extracellular matrices mimic the complex physiology of the human body to bring predictability & efficiency to drug discovery & diagnostics.
View company
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View company